Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $100.36 ($7.1M) on 2015-03-16, disclosed to the SEC on 2015-03-18.
Scheduled sale ($7.1M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.36 | 32,097 | $3.2M | 45.7% |
| 2 | $101.18 | 37,903 | $3.8M | 54.3% |
| Total | $100.80 avg | 70,000 | $7.1M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |